49 related articles for article (PubMed ID: 38531953)
21. Disulfidptosis: a new target for metabolic cancer therapy.
Zheng P; Zhou C; Ding Y; Duan S
J Exp Clin Cancer Res; 2023 Apr; 42(1):103. PubMed ID: 37101248
[TBL] [Abstract][Full Text] [Related]
22. HOTAIR knockdown impairs metastasis of cervical cancer cells by down-regulating metastasis-related genes.
Shi L; Zhang D; Han H; Zhang L; Li S; Yang F; He C
J Obstet Gynaecol; 2023 Dec; 43(1):2181060. PubMed ID: 36972141
[TBL] [Abstract][Full Text] [Related]
23. [Cancer statistics in China, 2016].
Zheng RS; Zhang SW; Sun KX; Chen R; Wang SM; Li L; Zeng HM; Wei WW; He J
Zhonghua Zhong Liu Za Zhi; 2023 Mar; 45(3):212-220. PubMed ID: 36944542
[No Abstract] [Full Text] [Related]
24. Identification and validation of a novel cuproptosis-related genes signature associated with prognosis, clinical implications and immunotherapy of hepatocellular carcinoma.
He F; Zeng P; Ma S; Yang X; Liu H; Liu Q; Zhou Y; Zhu H
Front Pharmacol; 2023; 14():1088993. PubMed ID: 36843949
[No Abstract] [Full Text] [Related]
25. Actin cytoskeleton vulnerability to disulfide stress mediates disulfidptosis.
Liu X; Nie L; Zhang Y; Yan Y; Wang C; Colic M; Olszewski K; Horbath A; Chen X; Lei G; Mao C; Wu S; Zhuang L; Poyurovsky MV; James You M; Hart T; Billadeau DD; Chen J; Gan B
Nat Cell Biol; 2023 Mar; 25(3):404-414. PubMed ID: 36747082
[TBL] [Abstract][Full Text] [Related]
26. LINC02870 facilitates SNAIL translation to promote hepatocellular carcinoma progression.
Guo M; Zhuang H; Huang J; Shao X; Bai N; Li M; Niu M; Wei W; Sun L; Li Y; Qiang Z
Mol Cell Biochem; 2023 Sep; 478(9):1899-1914. PubMed ID: 36583796
[TBL] [Abstract][Full Text] [Related]
27. Constructing and Validating a Pyroptosis-Related Genes Prognostic Signature for Stomach Adenocarcinoma and Immune Infiltration: Potential Biomarkers for Predicting the Overall Survival.
Xu J; Chen K; Wei Z; Wu Z; Huang X; Cai M; Yuan K; Huang P; Zhang J; Wang S
J Oncol; 2022; 2022():3102743. PubMed ID: 36199800
[TBL] [Abstract][Full Text] [Related]
28. Construction of a ferroptosis-related five-lncRNA signature for predicting prognosis and immune response in thyroid carcinoma.
Qin Y; Zhang D; Zhang H; Hou L; Wang Z; Yang L; Zhang M; Zhao G; Yao Q; Ling R; Zhang J
Cancer Cell Int; 2022 Sep; 22(1):296. PubMed ID: 36175889
[TBL] [Abstract][Full Text] [Related]
29. Cuproptosis-Related lncRNAs are Biomarkers of Prognosis and Immune Microenvironment in Head and Neck Squamous Cell Carcinoma.
Yang L; Yu J; Tao L; Huang H; Gao Y; Yao J; Liu Z
Front Genet; 2022; 13():947551. PubMed ID: 35938003
[No Abstract] [Full Text] [Related]
30. TP53 mutation is enriched in colorectal cancer liver metastasis in the context of polyclonal seeding.
Sun W; Sun Q; Zhong A; Lyne AM; Huang D; Han F; Lai M; Zhang H
Pathol Res Pract; 2022 Aug; 236():153958. PubMed ID: 35679752
[TBL] [Abstract][Full Text] [Related]
31. Pyroptosis-related lncRNAs are potential biomarkers for predicting prognoses and immune responses in patients with UCEC.
Liu J; Geng R; Ni S; Cai L; Yang S; Shao F; Bai J
Mol Ther Nucleic Acids; 2022 Mar; 27():1036-1055. PubMed ID: 35228898
[TBL] [Abstract][Full Text] [Related]
32. SOX9/MKLN1-AS Axis Induces Hepatocellular Carcinoma Proliferation and Epithelial-Mesenchymal Transition.
Guo C; Zhou S; Yi W; Yang P; Li O; Liu J; Peng C
Biochem Genet; 2022 Dec; 60(6):1914-1933. PubMed ID: 35138470
[TBL] [Abstract][Full Text] [Related]
33. Targeting cancer metabolism in the era of precision oncology.
Stine ZE; Schug ZT; Salvino JM; Dang CV
Nat Rev Drug Discov; 2022 Feb; 21(2):141-162. PubMed ID: 34862480
[TBL] [Abstract][Full Text] [Related]
34. Long non-coding RNA TMCC1-AS1 predicts poor prognosis and accelerates epithelial-mesenchymal transition in liver cancer.
Chen C; Su N; Li G; Shen Y; Duan X
Oncol Lett; 2021 Nov; 22(5):773. PubMed ID: 34589152
[TBL] [Abstract][Full Text] [Related]
35. Study of lncRNA TPA in Promoting Invasion and Metastasis of Breast Cancer Mediated by TGF-β Signaling Pathway.
Li Q; Mo W; Ding Y; Ding X
Front Cell Dev Biol; 2021; 9():688751. PubMed ID: 34422811
[TBL] [Abstract][Full Text] [Related]
36. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Sung H; Ferlay J; Siegel RL; Laversanne M; Soerjomataram I; Jemal A; Bray F
CA Cancer J Clin; 2021 May; 71(3):209-249. PubMed ID: 33538338
[TBL] [Abstract][Full Text] [Related]
37. A novel autophagy-related lncRNA prognostic risk model for breast cancer.
Li X; Jin F; Li Y
J Cell Mol Med; 2021 Jan; 25(1):4-14. PubMed ID: 33216456
[TBL] [Abstract][Full Text] [Related]
38. Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy.
Koppula P; Zhuang L; Gan B
Protein Cell; 2021 Aug; 12(8):599-620. PubMed ID: 33000412
[TBL] [Abstract][Full Text] [Related]
39. Identification of a prognostic signature of epithelial ovarian cancer based on tumor immune microenvironment exploration.
Liu J; Meng H; Nie S; Sun Y; Jiang P; Li S; Yang J; Sun R; Cheng W
Genomics; 2020 Nov; 112(6):4827-4841. PubMed ID: 32890701
[TBL] [Abstract][Full Text] [Related]
40. Regulation of long non-coding RNAs and genome dynamics by the RNA surveillance machinery.
Nair L; Chung H; Basu U
Nat Rev Mol Cell Biol; 2020 Mar; 21(3):123-136. PubMed ID: 32020081
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
